TBIQYR856-Global Swine Vaccines Market Research Report 2019

                                          
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

The classification of Swine Vaccines includes CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines and Other Vaccines. The proportion of T CSF Vaccines in 2017 is about 44%. 
Swine Vaccines is application in Government Tender and Market Sales. The most of Swine Vaccines are Market Sales, and the market share in 2017 is about 89%. 
China is the largest consumption place, with a consumption market share nearly 56% in 2017. Following China, Europe is the second largest consumption place with the consumption market share of 19% in 2017. 

The global Swine Vaccines market is valued at 1180 million US$ in 2018 is expected to reach 1610 million US$ by the end of 2025, growing at a CAGR of 4.0% during 2019-2025.
This report focuses on Swine Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Swine Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Merck
    Boehringer Ingelheim
    Jinyu Bio-Technology
    CAHIC
    Tecon
    Zoetis
    Ceva
    Hile Bio
    Chopper Biology
    WINSUN
    Hipra
    Ringpu Biology
    ChengDu Tecbond
    DHN
    CAVAC
    Virbac
    HVRI
    Bioveta

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    CSF Vaccines
    FMD Vaccines
    Porcine Circovirus Vaccines
    PRRS Vaccines
    Other

Segment by Application
    Government Tender
    Market Sales